Highland Capital Management LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 6.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 36,299 shares of the company’s stock after selling 2,509 shares during the period. Highland Capital Management LLC’s holdings in Thermo Fisher Scientific were worth $5,774,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. Emerald Acquisition Ltd. acquired a new stake in shares of Thermo Fisher Scientific during the second quarter valued at $200,618,000. Sound Shore Management Inc. CT boosted its stake in shares of Thermo Fisher Scientific by 123.5% in the second quarter. Sound Shore Management Inc. CT now owns 2,204,253 shares of the company’s stock valued at $138,096,000 after buying an additional 1,217,950 shares during the last quarter. FMR LLC boosted its stake in shares of Thermo Fisher Scientific by 11.3% in the second quarter. FMR LLC now owns 8,216,645 shares of the company’s stock valued at $1,214,093,000 after buying an additional 834,858 shares during the last quarter. Carmignac Gestion boosted its stake in shares of Thermo Fisher Scientific by 23.3% in the second quarter. Carmignac Gestion now owns 4,046,550 shares of the company’s stock valued at $597,918,000 after buying an additional 763,421 shares during the last quarter. Finally, Janus Capital Management LLC boosted its stake in shares of Thermo Fisher Scientific by 50.5% in the second quarter. Janus Capital Management LLC now owns 1,972,203 shares of the company’s stock valued at $291,410,000 after buying an additional 661,475 shares during the last quarter. 86.28% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) traded up 0.70% during mid-day trading on Tuesday, reaching $141.30. 2,186,608 shares of the company traded hands. The stock’s 50 day moving average price is $149.29 and its 200 day moving average price is $151.92. Thermo Fisher Scientific Inc. has a 52 week low of $119.75 and a 52 week high of $160.68. The firm has a market capitalization of $55.82 billion, a price-to-earnings ratio of 28.24 and a beta of 1.24.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Thursday, October 27th. The company reported $2.03 earnings per share for the quarter, topping the consensus estimate of $1.97 by $0.06. The business earned $4.49 billion during the quarter, compared to the consensus estimate of $4.39 billion. Thermo Fisher Scientific had a net margin of 11.10% and a return on equity of 14.95%. The company’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.80 EPS. Equities analysts forecast that Thermo Fisher Scientific Inc. will post $8.25 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 16th. Stockholders of record on Thursday, December 15th will be given a dividend of $0.15 per share. The ex-dividend date is Tuesday, December 13th. This represents a $0.60 annualized dividend and a dividend yield of 0.42%. Thermo Fisher Scientific’s dividend payout ratio is presently 12.00%.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2016/11/29/highland-capital-management-llc-decreases-stake-in-thermo-fisher-scientific-inc-tmo.html.

A number of equities research analysts recently commented on the stock. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $178.00 target price for the company in a research report on Monday, August 1st. Bank of America Corp. set a $180.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Friday, October 7th. Jefferies Group reissued a “hold” rating on shares of Thermo Fisher Scientific in a research report on Thursday, August 4th. JPMorgan Chase & Co. assumed coverage on shares of Thermo Fisher Scientific in a research report on Thursday, September 22nd. They set an “overweight” rating and a $180.00 target price for the company. Finally, Leerink Swann assumed coverage on shares of Thermo Fisher Scientific in a research report on Thursday, November 10th. They set an “outperform” rating and a $175.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $164.37.

In other news, CEO Marc N. Casper sold 28,797 shares of the business’s stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $151.01, for a total transaction of $4,348,634.97. Following the completion of the sale, the chief executive officer now owns 307,444 shares in the company, valued at approximately $46,427,118.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Marc N. Casper sold 30,000 shares of the business’s stock in a transaction that occurred on Thursday, September 1st. The stock was sold at an average price of $151.17, for a total transaction of $4,535,100.00. Following the sale, the chief executive officer now owns 308,647 shares of the company’s stock, valued at approximately $46,658,166.99. The disclosure for this sale can be found here. Insiders own 0.52% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.